small cell lung cancer


Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.

small cell lung cancer

n.
A highly malignant carcinoma of the lungs, composed of small ovoid undifferentiated cells. Also called oat cell carcinoma, small cell carcinoma.
References in periodicals archive ?
- Tecentriq, an Anti-PD-L1 Antibody, Receives Approval for Additional Indication of Extensive-Stage Small Cell Lung Cancer
Small cell lung cancer and non-small cell lung cancer are the two main types of lung cancer.
Lung cancer is divided into two main subtypes, non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
Lung cancer can be broadly classified into two major types - non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
To the Editor: Small cell lung cancer (SCLC) transformation is one of the most common mechanisms of resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in non-SCLC (NSCLC).
Maryland Heights, MO, May 06, 2017 --(PR.com)-- Non-small cell lung cancer (NSCLC) is the most common type of lung cancer (about 85% of lung cancers) and it usually grows and spreads more slowly than small cell lung cancer. Squamous cell carcinoma, adenocarcinoma, and large cell carcinoma are all subtypes of non-small cell lung cancer.
There are around 45,500 new cases of lung cancer in the UK every year, and about 12% of these are small cell lung cancer.
Results of the randomized international adjuvant lung cancer trial (IALT) cisplatin-based chemotherapy (CT) versus no CT in 1867 patients with resected non- small cell lung cancer. Annual Meeting of the American Society of Clinical Oncology (ASCO).
Using whole-genome profiling, MIT scientists have pinpointed a gene that appears to drive progression of small cell lung cancer.
Small cell lung cancer kills about 95 percent of patients within five years of diagnosis; scientists do not yet have a good understanding of which genes control it.
We postulate that adenocarcinoma could be the most frequently observed variant, and provide an overview of the staging of all the cases of non-small cell and small cell lung cancer patients included.
The chapter on FDG- PET/CT in Lung Cancer: An Update, describe the importance of PET-CT in initial diagnosis, evaluation of therapy response, detection of recurrent tumour, radiation therapy planning and the multidisciplinary management of patients with NSCLC and small cell lung cancer. The chapter on Whole-body MRI for Staging of Lung Cancer gives an overview of initial clinical results obtained with whole-body MRI in staging lung cancer.